Gap Junction Protein, alpha 8, 50kDa (GJA8) Peptid
Kurzübersicht für Gap Junction Protein, alpha 8, 50kDa (GJA8) Peptid (ABIN937767)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- EEQEKVAVPE GEKVETPGVD KEGEKEEPQS EKVSKQGLPA EKTPSLCPEL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GJA8 antibody,
Alternative Names: GJA8 control peptide, GJA8 antibody Blocking Peptide, Anti-GJA8 Blocking Peptide, Gap Junction Protein Alpha 8 50Kda Blocking Peptide, CAE Blocking Peptide, CAE1 Blocking Peptide, CX50 Blocking Peptide, CZP1 Blocking Peptide, MP70 Blocking Peptide, GJA8, GJA-8, GJA 8, GJA-8 Blocking Peptide, GJA 8 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
-
Hintergrund
- One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. Defects in GJA8 are the cause of zonular pulverulent cataract type 1 (CZP1).
-
Molekulargewicht
- 48 kDa
Target
-